Uridine is a natural building block of genetic material and brain-cell membranes. Two prescription uses are proven; for memory and brain aging in healthy adults, human evidence is thin and experts disagree whether swallowed uridine reaches the brain. It is inexpensive and generally well tolerated, but its benefits remain unproven. (Full Review)

Protocol

Dose

UMP 150–500 mg/day

Combined with a choline source and omega-3 fish oil (DHA)

Form

UMP or TAU

Triacetyluridine (TAU) raises plasma uridine ~four-fold, so doses are lower

Timing

Morning, with first meal

Split (twice-daily) dosing sometimes used given the short half-life

Time to effect

Mood & Focus

Days to a few weeks

Subjective mood or focus changes, where reported

Membrane Effects

Weeks to months

Structural brain cell membrane benefits would be expected only over this span

Healthy Adults

No reliable timeline

No reliable human timeline exists for healthy adults

Benefits

High: Rescue from fluorouracil/capecitabine toxicity; treatment of hereditary orotic aciduria

Medium: Reduction of depressive symptoms

Low: Cognitive and memory support; support of mitochondrial and bioenergetic function

Speculative: Neuroprotection and healthy brain aging; anti-epileptic and neuromodulatory effects

Contraindications

Fluoropyrimidine chemotherapy (fluorouracil, capecitabine, tegafur)

Pregnancy or breastfeeding

Key Interactions

Gout or significantly elevated uric acid

Significant kidney impairment

High-dose NSAIDs in people prone to gout (ibuprofen, naproxen)

Choline sources (alpha-GPC, CDP-choline/citicoline) and omega-3 fish oil (DHA)

Acetylcholine-related nootropics (centrophenoxine, racetams)

Risk & Side Effects

High: Gastrointestinal upset

Medium: Elevated uric acid and gout risk

Low: Cardiovascular/hemodynamic effects; reduced chemotherapy efficacy

Speculative: Long-term safety unknown; fetal/developmental effects

Monitoring

Marker	Target	Why
Serum uric acid	3.5–6.0 mg/dL (men), 2.5–5.5 mg/dL (women)	Detects any urate rise that could trigger gout
eGFR	>90 mL/min/1.73m²	Uridine is renally cleared; reduced function raises exposure
Comprehensive metabolic panel	Within normal limits	General safety screen for liver/kidney/electrolytes
Homocysteine	<8 µmol/L	Context for the choline/methylation pathway uridine feeds into

Cadence: Generally only needed in at-risk users: recheck uric acid at roughly 3 months, then every 6–12 months if continued

Qualitative Assessment

Subjective memory, focus, and mental clarity
Mood and motivation
Energy levels and sense of mental stamina
Absence of side effects such as nausea, headache, or gout symptoms

Uridine for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment